Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | %Female (2011) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
170 | Advances in Pharmacological Sciences | journal | 0.270 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
169 | Cellular oncology (Dordrecht) | journal | 58 | 52 | 0 | 2170 | 0 | 0 | 0.00 | 41.73 | 42.45 | ||
168 | Drugs in Context | journal | 0.101 Q4 | 36 | 0 | 20 | 0 | 0 | 18 | 0.00 | 0.00 | 0.00 | |
167 | Journal of Experimental Pharmacology | journal | 0.121 Q4 | 23 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
166 | MedChemComm | journal | 0.962 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
165 | Nucleus (India) | journal | 17 | 4 | 0 | 84 | 0 | 0 | 0.00 | 21.00 | 50.00 | ||
164 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.103 Q4 | 40 | 0 | 6 | 0 | 0 | 6 | 0.00 | 0.00 | 0.00 | |
163 | Sp2 | trade journal | 0.101 Q4 | 2 | 51 | 138 | 28 | 1 | 124 | 0.01 | 0.55 | 15.15 | |
162 | Frontiers in Genetics | journal | 0.147 Q4 | 120 | 94 | 2 | 4222 | 2 | 2 | 1.00 | 44.91 | 35.46 | |
161 | Gene Therapy and Regulation | journal | 0.104 Q4 | 7 | 6 | 12 | 338 | 2 | 11 | 0.17 | 56.33 | 22.22 | |
160 | Open Bioactive Compounds Journal | journal | 0.115 Q4 | 6 | 0 | 6 | 0 | 2 | 6 | 0.33 | 0.00 | 0.00 | |
159 | Topics in Medicinal Chemistry | book series | 0.108 Q4 | 15 | 8 | 25 | 1218 | 2 | 19 | 0.08 | 152.25 | 29.63 | |
158 | 2010 IEEE International Conference on Nano/Molecular Medicine and Engineering, IEEE NANOMED 2010 | conference and proceedings | 0.100 | 5 | 0 | 53 | 0 | 3 | 50 | 0.06 | 0.00 | 0.00 | |
157 | Methods in Pharmacology and Toxicology | book series | 0.112 Q4 | 14 | 0 | 22 | 0 | 4 | 21 | 0.00 | 0.00 | 0.00 | |
156 | European Pharmaceutical Review | trade journal | 0.104 Q4 | 9 | 30 | 72 | 542 | 5 | 64 | 0.07 | 18.07 | 27.08 | |
155 | Forum on Immunopathological Diseases and Therapeutics | journal | 0.105 Q4 | 14 | 37 | 22 | 1362 | 5 | 21 | 0.23 | 36.81 | 37.27 | |
154 | Open Pharmacology Journal | journal | 0.384 Q3 | 6 | 1 | 9 | 28 | 6 | 9 | 0.67 | 28.00 | 33.33 | |
153 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.118 Q4 | 29 | 11 | 18 | 591 | 7 | 0 | 0.40 | 53.73 | 0.00 | |
152 | Frontiers in Drug Design and Discovery | book series | 0.134 Q4 | 9 | 0 | 18 | 0 | 8 | 17 | 0.44 | 0.00 | 0.00 | |
151 | Pharmacogenomics and Personalized Medicine | journal | 0.147 Q4 | 37 | 11 | 20 | 1128 | 9 | 20 | 0.45 | 102.55 | 51.11 | |
150 | Pteridines | journal | 0.113 Q4 | 19 | 12 | 35 | 444 | 9 | 34 | 0.23 | 37.00 | 43.75 | |
149 | 2009 IEEE 3rd International Conference on Nano/Molecular Medicine and Engineering, NANOMED 2009 | conference and proceedings | 0.114 | 6 | 0 | 70 | 0 | 11 | 69 | 0.16 | 0.00 | 0.00 | |
148 | Cellular Therapy and Transplantation | journal | 0.191 Q4 | 8 | 10 | 38 | 225 | 13 | 37 | 0.34 | 22.50 | 43.48 | |
147 | Frontiers in Medicinal Chemistry | book series | 0.233 Q4 | 7 | 0 | 44 | 0 | 13 | 42 | 0.30 | 0.00 | 0.00 | |
146 | Chinese Journal of Cancer Biotherapy | journal | 0.121 Q4 | 5 | 110 | 393 | 1780 | 17 | 389 | 0.04 | 16.18 | 41.63 | |
145 | Turkish Journal of Pharmaceutical Sciences | journal | 0.170 Q4 | 22 | 25 | 68 | 649 | 18 | 68 | 0.24 | 25.96 | 46.27 | |
144 | Journal of Stem Cells | journal | 0.265 Q4 | 21 | 32 | 44 | 1894 | 25 | 43 | 0.92 | 59.19 | 44.19 | |
143 | Open Medicinal Chemistry Journal | journal | 0.921 Q2 | 23 | 13 | 7 | 776 | 25 | 6 | 3.57 | 59.69 | 56.00 | |
142 | Analytical Cellular Pathology | journal | 0.365 Q4 | 35 | 27 | 25 | 1153 | 27 | 24 | 1.08 | 42.70 | 42.11 | |
141 | Current Enzyme Inhibition | journal | 0.183 Q4 | 19 | 25 | 63 | 2002 | 28 | 61 | 0.49 | 80.08 | 39.47 | |
140 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 0.124 Q4 | 16 | 57 | 162 | 2128 | 32 | 162 | 0.29 | 37.33 | 56.18 | |
139 | Current Cancer Therapy Reviews | journal | 0.143 Q4 | 17 | 28 | 104 | 3131 | 34 | 102 | 0.35 | 111.82 | 35.44 | |
138 | Current Chemical Genomics | journal | 0.588 Q3 | 16 | 13 | 16 | 655 | 41 | 16 | 2.56 | 50.38 | 29.17 | |
137 | Methods in molecular medicine | book series | 0.261 Q4 | 59 | 0 | 67 | 0 | 41 | 66 | 0.00 | 0.00 | 0.00 | |
136 | Gene Therapy and Molecular Biology | journal | 0.181 Q4 | 18 | 0 | 68 | 0 | 45 | 68 | 0.90 | 0.00 | 0.00 | |
135 | Probiotics and Antimicrobial Proteins | journal | 0.419 Q3 | 52 | 25 | 36 | 1178 | 50 | 35 | 1.39 | 47.12 | 29.27 | |
134 | EXCLI Journal | journal | 0.165 Q4 | 55 | 44 | 48 | 1448 | 56 | 47 | 1.17 | 32.91 | 39.78 | |
133 | Progress in Drug Research | book series | 0.760 Q3 | 46 | 15 | 20 | 1405 | 61 | 18 | 0.00 | 93.67 | 20.69 | |
132 | Progress in Medicinal Chemistry | journal | 0.962 Q2 | 38 | 6 | 28 | 836 | 61 | 17 | 1.75 | 139.33 | 0.00 | |
131 | Drug Discovery Today: Therapeutic Strategies | journal | 0.375 Q3 | 31 | 23 | 71 | 651 | 63 | 60 | 0.68 | 28.30 | 31.65 | |
130 | BMC Chemical Biology | journal | 1.979 Q1 | 21 | 2 | 17 | 74 | 73 | 17 | 4.07 | 37.00 | 30.77 | |
129 | Clinical Proteomics | journal | 0.609 Q3 | 42 | 17 | 47 | 589 | 74 | 43 | 1.34 | 34.65 | 29.89 | |
128 | Drug Discovery Today: Disease Models | journal | 0.364 Q4 | 33 | 24 | 79 | 1114 | 74 | 68 | 0.63 | 46.42 | 35.94 | |
127 | MCB Molecular and Cellular Biomechanics | journal | 0.551 Q3 | 31 | 18 | 56 | 629 | 79 | 56 | 1.06 | 34.94 | 32.65 | |
126 | Drug Discovery Today: Technologies | journal | 0.414 Q3 | 62 | 18 | 64 | 601 | 89 | 56 | 1.15 | 33.39 | 21.74 | |
125 | Genetic Vaccines and Therapy | journal | 0.758 Q3 | 30 | 15 | 36 | 621 | 93 | 36 | 1.85 | 41.40 | 42.86 | |
124 | Virologica Sinica | journal | 0.285 Q4 | 47 | 49 | 170 | 1188 | 96 | 169 | 0.63 | 24.24 | 36.06 | |
123 | Drug Discovery Today: Disease Mechanisms | journal | 0.504 Q3 | 28 | 15 | 78 | 807 | 107 | 70 | 1.15 | 53.80 | 30.77 | |
122 | Current Pharmaceutical Analysis | journal | 0.417 Q3 | 27 | 37 | 86 | 1517 | 111 | 85 | 1.29 | 41.00 | 42.28 | |
121 | Current Pharmacogenomics and Personalized Medicine | journal | 0.291 Q4 | 20 | 30 | 85 | 2789 | 112 | 75 | 1.61 | 92.97 | 41.79 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®